RenovoRx Announces $11.1 Million at Market Private PlacementBusiness Wire • about 2 months agoRenovoRx, Inc. (RenovoRx or the Company) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today...